Evidence map›Paper›PMID 37021002›Full record

ArticleFrontiers in genetics2023

The 10th Santorini conference: Systems medicine, personalised health and therapy. "The odyssey from hope to practice: Patient first.

Sophie Visvikis-Siest, Maria G Stathopoulou, Raute Sunder-Plassmann, Behrooz Z Alizadeh, Robert Barouki, Ekaterina Chatzaki, Georges Dagher, George Dedoussis, Panagiotis Deloukas, Alexander Haliassos and 22 more

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Sophie Visvikis-SiestEA_1122 IGE-PCV, Université de Lorraine, Nancy, France.
Maria G StathopoulouTeam 10: Control of Gene Expression, INSERM U, Centre Méditerranéen de Médecine Moléculaire C3M, Nice, France.
Raute Sunder-PlassmannDepartment of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
Behrooz Z AlizadehUnit of Personalized Medicine, Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, Netherland.
Robert BaroukiUniversité de Paris, Inserm unit 1124 (T3S), Paris, France.
Ekaterina ChatzakiLaboratory of Pharmacology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.
Georges DagherInserm, Paris, France.
George DedoussisDepartment of Nutrition and Dietetics, Harokopio University of Athens, Athens, Greece.
Panagiotis Deloukas13 William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Alexander HaliassosEurSpLM, ESEAP, The Greek Proficiency Testing Scheme for Clinical Laboratories Athens, Athens, Greece.
Brigitte Boisson HiegelEA_1122 IGE-PCV, Université de Lorraine, Nancy, France.
Vangelis ManolopoulosLaboratory of Pharmacology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.
Christine MassonEA_1122 IGE-PCV, Université de Lorraine, Nancy, France.
Guillaume ParéPopulation Health Research Institute, Genetic and Molecular Epidemiology Laboratory, McMaster University, Hamilton, ON, Canada.
Markus PaulmichlPrivatklinik Maria Hilf, Klagenfurt, Austria.
Alexandros M PetrelisEA_1122 IGE-PCV, Université de Lorraine, Nancy, France.
Csilla SipekyUCB Pharma, Translational Medicine, Precision Medicine and Biomarkers, Genetics, Braine-l'Alleud, Belgium.
Belgin SüsleyiciMarmara University, Faculty of Sciences and Letters, Department of Molecular Biology, Istanbul, Türkiye.
Georges WeryhaEA_1122 IGE-PCV, Université de Lorraine, Nancy, France.
Alex ChenchikCellecta, Inc, Mountain View, CA, United States.
Paul DiehlCellecta, Inc, Mountain View, CA, United States.
Robin E EvertsAgena Bioscience, San Diego, CA, United States.
Alexander HaushoferInst. f. Med. u. Chem. Labordiagnostik, Klinikum Wels-Grieskirchen GmbH, Wels, Austria.
John LamontRandox Laboratories Limited, Crumlin, Co. Antrim, United Kingdom.
Ruth MercadoCellecta, Inc, Mountain View, CA, United States.
Heiko MeyerAgena Bioscience, Hamburg, Germany.
Herna Munoz-GaleanoHMG Systems Engineering GmbH, Fürth, Germany.
Helena MurrayRandox Laboratories Limited, Crumlin, Co. Antrim, United Kingdom.
Ferrier NhatThermo Fisher Scientific, San Francisco, CA, United States.
Charity NofzigerPharmGenetix GmbH, Anif/Niederalm, Austria.
Wolfgang SchnitzelPharmGenetix GmbH, Anif/Niederalm, Austria.
Stavroula Kanoni13 William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancergenetic screeningheart inflammationmedical diagnostic“-OMICs” biomarkerspersonalized medicinepharmacogenomicssystems medicine

Identifiers

PMID37021002
PMCPMC10069673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.